Skip to main content
NSCLC Management of RET Mutations

NSCLC Management of RET Mutations

Dr. Aggarwal Discusses Management of "Rare" Oncogenic Drivers in NSCLC- An Interactive Case Based Discussion

Dr. Aggarwal Discusses Management of "Rare" Oncogenic Drivers in NSCLC- An Interactive Case Based Discussion

Scroll to Continue

Recommended Articles

Multiple Myeloma
Multiple Myeloma Overviews

Treatment for Stage II - III Multiple Myeloma

Treatment of stage II-III myeloma may include chemotherapy, precision medicines, stem cell transplant & supportive care.

By Dr. C.H. Weaver M.D.
Ovarian News & Updates
Ovarian Cancer Treatment

Checkpoint Inhibitors + Avastin for Recurrent Ovarian Cancer

Anit-angiogenic - immunotherapy combination represents new treatment option for recurrent ovarian cancer.

By Dr. C.H. Weaver M.D.

Atalante Clinical Trial

You May Like

NSCLCAggarwal1620c
MD

NSCLC Management of ALK Mutations

Advances in the Management of "Rare" Oncogenic Drivers in NSCLC- An Interactive Case Based Discussion

By CancerConnect
NSCLCAggarwal1620c
MD

NSCLC NTRK Case Base Discussion Series

Advances in the Management of “Rare” Oncogenic Drivers in NSCLC- An Interactive Case Based Discussion

By CancerConnect
Saab Colorectal
MD

Stivarga for Advanced CRC – The ReDos Trial

Advances in the Management of Advanced Colorectal Cancer – A Case Based Discussion

By CancerConnect
Aggarwal Kucharczuk
MD

Adjuvant therapy for Early Stage Lung Cancer – Case Based Discussion for Patient with Stage 1B NSCLC

By CancerConnect
Saab Hepatocellular Cancer
MD

Advances in the Management of Advanced Hepatocellular Cancer

Advances in the Management of Advanced Hepatocellular Cancer

By CancerConnect
Image placeholder title
Treatment & Care

Managing Locally Advanced NSCLC in the Elderly

Managing Locally Advanced NSCLC in the Elderly

By CancerConnect
Aggarwal Kucharczuk
MD

Molecular Testing and Implications for Adjuvant Therapy in Early Stage NSCLC

Dr. Charu Aggarwal, MD, MPH and Dr. John Kucharczuk, MD

By CancerConnect
Aggarwal Kucharczuk
MD

Post ESMO Update on IMPower Clinical Trial in Early Stage NSCLC

Post ESMO Update on IMPower Clinical Trial in Early Stage NSCLC

By CancerConnect
Strickler Colorectal Cancer Case Base Discussion Series
MD

The “Circulate” Clinical Trial - ctDNA Dynamics and Clinical Outcomes in Colon Cancer

Dr John Stricker discusses what the recent data from "Circulate" tells us about integrating MRD assays into clinical practice?

By CancerConnect